2,478
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform

, , , , , & show all
Article: 20056 | Received 20 Nov 2012, Accepted 08 Jan 2013, Published online: 01 Mar 2013

References

  • Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, et al.. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet. 2012; 379: 2173–8.10.3402/gha.v6i0.20056.
  • World Health Organization. Measles vaccines: WHO position paper. Weekly Epidemiological Record. 2009; 84: 349–60.
  • World Health Organization. 2012Retrospective measles data on supplementary immunization activities 2000–2010. Available from: http://www.who.int/immunization_monitoring/data/Summary_Measles_SIAs_2000_to_2011.xls [cited 6 July 2012]..
  • de Quadros CA, Izurieta H, Venczel L, Carrasco P. Measles eradication in the Americas: progress to date. J Infect Dis. 2004; 189(Suppl. 1):S227–35.10.3402/gha.v6i0.20056.
  • Biellik R, Madema S, Taole A, Kutsulukuta A, Allies E, Eggers R, et al.. First 5 years of measles elimination in southern Africa. Lancet. 2002; 359: 1564–68.10.3402/gha.v6i0.20056.
  • Sepúlveda J, Bustreo F, Tapia R, Rivera J, Lozano R, Oláiz G, et al.. Improvement of child survival in Mexico: the diagonal approach. Lancet. 2006; 368: 2017–27.10.3402/gha.v6i0.20056.
  • World Health Organization/UNICEF. (2009). Joint annual measles report 2009. Strengthening immunization services through measles control. Geneva: WHO.
  • Grabowsky M, Nobiya T, Ahun M, Donna R, Lengor M, Zimmerman D, et al.. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage. Bull World Health Organ. 2005; 83: 195–201.
  • Grabowsky M, Farrell N, Hawley W, Chimumbwa J, Hoyer S, Wolkon A, et al.. Integrating insecticide-treated bednets into a measles vaccination campaign achieves high, rapid and equitable coverage with direct and voucher-based methods. Trop Med Int Health. 2005; 10: 1151–60.10.3402/gha.v6i0.20056.
  • Doherty T, Chopra M, Tomlinson M, Oliphant N, Nsibande D, Mason J, et al.. Moving from vertical to integrated child health programmes: experiences from a multi-country assessment of the Child Health Days approach in Africa. Trop Med Int Health. 2010; 15: 296–305.10.3402/gha.v6i0.20056.
  • Uzicanin A, Eggers R, Webb E, Harris B, Durrheim D, Ogunbajo G, et al.. Impact of the 1996–1997 supplementary measles vaccination campaign in South Africa. Int J Epidemiol. 2002; 31: 968–76.10.3402/gha.v6i0.20056.
  • World Health Organization. 2012Health topics/poliomyelitis. Polio incidence time series. Available from: http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tsincidencedip.htm [cited 8 November 2012].
  • Institute for Health Metrics and Evaluation. (2012). IHME database. Seattle WA: IHME.
  • Labadarios D. The National Food Consumption Survey – Fortification Baseline (NFCS – FB): the knowledge, attitude, behavior and procurement regarding fortified foods, a measure of hunger and the anthropometric and selected micronutrient status of children aged 1–9 years and women of child bearing age: South Africa, 2005. Pretoria: Department of Health, Nutrition Directorate. 2007.
  • Brooker S, Clements ACA, Bundy DAP. Global epidemiology, ecology and control of soil-transmitted helminth infections. Adv Parasitol. 2006; 62: 221–61.
  • Mueller DH, Wiseman V, Bakusa D, Morgah K, Daré A, Tchamdja P, et al.. Cost-effectiveness analysis of insecticide-treated net distributions as part of the Togo Integrated Child Health Campaign. Malar J. 2008; 7: 73.10.3402/gha.v6i0.20056.
  • Fiedler JL, Chuko T. The cost of child health days: a case study of Ethiopia's enhanced outreach strategy (EOS). Health Policy Plan. 2008; 23: 222–33.10.3402/gha.v6i0.20056.
  • Uzicanin A, Zhou F, Eggers R, Webb E, Strebel P. Economic analysis of the 1996–1997 mass measles immunization campaigns in South Africa. Vaccine. 2004; 22: 3419–26.10.3402/gha.v6i0.20056.
  • Acharya A, Diaz-Ortega JL, Tambini G, de Quadros C, Artia I. Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis. Vaccine. 2002; 20: 3332–41.10.3402/gha.v6i0.20056.
  • Dabral M. Cost-effectiveness of supplementary immunization for measles in India. Indian Pediatr. 2009; 46: 957–62.
  • Dayan GH, Cairns L, Sangrujee N, Mtonga A, Nguyen V, Strebel P, et al.. Cost-effectiveness of three different strategies against measles in Zambian children. Vaccine. 2004; 22: 475–84.10.3402/gha.v6i0.20056.
  • Levin A, Burgess C, Garrison LP, Bauch C, Babigumira J, Simons E, et al.. Global eradication of measles: an epidemiologic and economic evaluation. J Infect Dis. 2011; 204(Suppl. 1):S98–106.10.3402/gha.v6i0.20056.
  • Bishai D, Johns B, Nair D, Nabyonga-Orem J, Fiona-Makmot B, Simons E, et al.. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda. J Infect Dis. 2011; 204(Suppl. 1):S107–15.10.3402/gha.v6i0.20056.
  • Murray CJL, Rajaratnam JK, Marcus J, Laakso T, Lopez AD. What can we conclude from death registration? Improved methods for evaluating completeness. PloS Medicine. 2010; 7(4):e1000262.10.3402/gha.v6i0.20056.
  • Birnbaum JK, Murray CJL, Lozano R. Exposing misclassified HIV/AIDS deaths in South Africa. Bull World Health Organ. 2011; 89(4):278–85.10.3402/gha.v6i0.20056.
  • Imdad A, Herzer K, Mayo-Wilson E, Yakoob MY, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of age. Cochrane Database Syst Rev. 2010. Art. No.CD008524.
  • Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol. 2009; 28: 192–205.
  • Caulfield LE, Richard SA, Rivera JA, Musgrove P, Black RE. Stunting, wasting, and micronutrient deficiency disorders. Disease control priorities in developing countries2nd ed. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al..The World Bank. Washington DC, 2006; 351–367.
  • Babigumira JB, Levin A, Burgess C, Garrison LP, Bauch CT, Braka F, et al.. Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program. J Infect Dis. 2011; 204(Suppl. 1):S116–23.10.3402/gha.v6i0.20056.
  • Laxminarayan R, Mills AJ, Breman JG, Measham AR, Alleyne G, Cleason M, et al.. Advancement of global health: key messages from the Disease Control Priorities Project. Lancet. 2006; 367: 1193–208.10.3402/gha.v6i0.20056.
  • Aaby P, Bhuiya A, Nahar L, Knudsen K, de Francisco A, Strong M. The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh. Int J Epidemiol. 2003; 32: 106–15.10.3402/gha.v6i0.20056.
  • Fine PEM. Commentary: non-specific effects of measles vaccine – more grist for the mill. Int J Epidemiol. 2003; 32: 116–7.10.3402/gha.v6i0.20056.
  • Hotez PJ, Bundy DAP, Beegle K, Brooker S, Drake L, de Silva N, et al.Helminth infections: soil-transmitted helminth infections and schistosomiasis. Disease control priorities in developing countries2nd ed. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al..The World Bank. Washington DC, 2006; 467–482.
  • Musgrove P, Fox-Rushby J. Cost-effectiveness analysis for priority setting, Chapter 15. Disease control priorities in developing countries2nd ed. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al..The World Bank. Washington DC, 2006; 271–285.
  • Kahn MM, Ehreth J. Costs and benefits of polio eradication: a long-run global perspective. Vaccine. 2003; 21: 702–5.10.3402/gha.v6i0.20056.
  • Verguet S, Jassat W, Hedberg C, Tollman S, Jamison DT, Hofman KJ. Measles control in sub-Saharan Africa: South Africa as a case study. Vaccine. 2012; 30: 1594–600.10.3402/gha.v6i0.20056.
  • Bhutta ZA, Chopra M, Axelson H, Berman P, Boerma T, Bryce J, et al.. Countdown to 2015 decade report (2000–10): taking stock of maternal, newborn, and child survival. Lancet. 2010; 375: 2032–44.10.3402/gha.v6i0.20056.
  • Christie A, Gay A. Response toHeymann DL, Fine PE, Girffiths UK, Hall AJ, Mounier-Jack S. Measles eradication: past is prologue. Lancet. 2010; 376:1719–20. Lancet 2011;377:808.10.3402/gha.v6i0.20056.
  • Goodson JL, Kulkarni MA, Vanden Eng JL, Wannemuehler KA, Cotte AH, Desrochers RE, et al.. Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar. Trop Med Int Health. 2012; 17: 430–7.10.3402/gha.v6i0.20056.
  • World Health Organization. 2012The reaching every district strategy. Available from: http://www.who.int/immunization_delivery/systems_policy/RED-FactSheet.pdf [cited 14 August 2012].